Effects of repeated testing in two inbred strains on fiesinoxan dose-response curves in three mouse models for anxiety

被引:33
作者
Bouwknecht, JA
van der Gugten, J
Groenink, L
Olivier, B
Paylor, RE
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Univ Utrecht, Fac Pharm, Dept Psychopharmacol, NL-3584 CA Utrecht, Netherlands
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[4] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA
关键词
physiology; behavior; animal model; flesinoxan; repeated testing; 5-HT1A receptor;
D O I
10.1016/j.ejphar.2004.04.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the last decade, many genetically modified mice have been developed as models for psychiatric diseases such as anxiety. Limited availability of such mutant mice highlights the importance of studying the possibility of repeatedly testing the same individuals. We tested mice four times with 1-week intervals with the same dose of the 5-HT1A receptor agonist flesinoxan (0-0.3-1.0-3.0 mg/kg s.c.) in three anxiety-related paradigms: light-dark exploration, open-field activity and stress-induced hyperthermia. The two inbred strains studied were the highly anxious 129S6/SvEvTac (S6) and low-anxiety C57BL/6J (136) mice. The results indicate that the effects of repeated testing were relatively mild. 136 mice showed some mild habituation in the open-field test when treated with vehicle, whereas S6 mice developed reduced initial activity in the light-dark box after drug treatment. In contrast, responses to flesinoxan treatment were strong and highly consistent for most parameters. In the open-field and light-dark tests, 136 mice showed reduced activity and anxiogenic-like behavioral responses, whereas S6 mice were minimally affected. Anxiolytic-like responses were found in both strains in the stress-induced hyperthermia paradigm. We conclude that 136 and S6 mice can be tested repeatedly with agents such as 5-HT1A receptor agonists with 1-week intervals in the three paradigms tested. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 47 条
[21]   The mouse light-dark paradigm:: A review [J].
Hascoët, M ;
Bourin, M ;
Dhonnchadha, BAN .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (01) :141-166
[22]   Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine [J].
Holmes, A ;
Rodgers, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (2-3) :221-230
[23]   Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines [J].
Homanics, GE ;
Quinlan, JJ ;
Firestone, LL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 63 (01) :21-26
[24]   EFFECTS OF ANXIOLYTIC AND ANXIOGENIC DRUGS ON EXPLORATORY ACTIVITY IN A SIMPLE-MODEL OF ANXIETY IN MICE [J].
KILFOIL, T ;
MICHEL, A ;
MONTGOMERY, D ;
WHITING, RL .
NEUROPHARMACOLOGY, 1989, 28 (09) :901-905
[25]   Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat [J].
King, CMF ;
Gommans, J ;
Joordens, RJE ;
Hijzen, TH ;
Maes, RAA ;
Olivier, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (2-3) :121-128
[26]   Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear [J].
Li, XB ;
Inoue, T ;
Hashimoto, S ;
Koyama, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 425 (01) :43-50
[27]   Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F-1 hybrids: Implications of genetic background for single gene and quantitative trait loci analyses [J].
Logue, SF ;
Owen, EH ;
Rasmussen, DL ;
Wehner, JM .
NEUROSCIENCE, 1997, 80 (04) :1075-1086
[28]   The use of behavioral test batteries: Effects of training history [J].
McIlwain, KL ;
Merriweather, MY ;
Yuva-Paylor, LA ;
Paylor, R .
PHYSIOLOGY & BEHAVIOR, 2001, 73 (05) :705-717
[29]  
Misslin R, 1990, Neuroreport, V1, P267, DOI 10.1097/00001756-199011000-00025
[30]   Anxiolytic effects of flesinoxan in the stress-induced hyperthermia paradigm in singly-housed mice are 5-HT1A receptor mediated [J].
Olivier, B ;
Zethof, TJJ ;
Ronken, E ;
van der Heyden, JAM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) :177-182